Clinical Trial Update: Influence of N-Acetylcysteine on Morbidity, Oxygenation and Cytokine Levels in Partial or Total Esophagectomy for Cancer [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating whether N-acetylcysteine affects pulmonary morbidity, oxygenation and cytokine levels after partial or total esophagectomy for…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Pulmonary Morbidity | Phase 4 | Status: COMPLETED